Formic Acid

Formic Acid

SCHEMBL582968

N.O=CO.O=CO.[Pd]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL28012860 1.00
Formic Acid SCHEMBL2511100 0.94 ALDH1A1 (0.33)
Formic Acid SCHEMBL1545886 0.94 ALDH1A1 (0.33)
Formic Acid SCHEMBL83909 0.94
Formic Acid SCHEMBL1064783 0.94
Formic Acid SCHEMBL811681 0.94
Formic Acid SCHEMBL1545869 0.94 ALDH1A1 (0.33)
Formic Acid SCHEMBL18112628 0.94 ALDH1A1 (0.33)
Formic Acid SCHEMBL394887 0.94 ALDH1A1 (0.33)
Formic Acid SCHEMBL582126 0.94 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105985306-B The fully synthetic preparation method of natural products flavone compound 复旦大学 2018-10-26 CN claimed
CN-105985306-A Total synthesis preparation method of natural product flavonoid compounds 复旦大学 2016-10-05 CN claimed
WO-2024081372-A1 PROCESSES FOR THE PREPARATION OF THE AGENT-LINKER CONJUGATE CL2A-SN-38 AND THE IMMUNOCONJUGATES SACITUZUMAB GOVITECAN AND LABETUZUMAB GOVETICAN GILEAD SCIENCES, INC. (US) 2024-04-18 WO disclosed
CN-117616013-A Hydrogenated quinoxalines 大塚制药株式会社 2024-02-27 CN disclosed
WO-2022224035-A2 ANTI-GM1 ANTIBODY BINDING COMPOUNDS POLYNEURON PHARMACEUTICALS AG (CH) 2022-10-27 WO disclosed
CN-110437144-B Quinoline derivatives, preparation method and application thereof 东莞市东阳光农药研发有限公司 2021-03-26 CN disclosed
WO-2020212697-A1 INHIBITOR COMPOUNDS Azeria Therapeutics Limited (GB) 2020-10-22 WO disclosed
CN-105985306-B The fully synthetic preparation method of natural products flavone compound 复旦大学 2018-10-26 CN disclosed
CN-105985306-A Total synthesis preparation method of natural product flavonoid compounds 复旦大学 2016-10-05 CN disclosed
CN-103772379-B A kind of preparation method of trospium chloride key intermediate 寿光富康制药有限公司 2016-06-15 CN disclosed
WO-2014141118-A1 IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AND USES THEREOF Piramal Enterprises Limited (IN) 2014-09-18 WO disclosed
EP-0405748-A1 Phosphonoderivative of purine with antiviral activity Beecham Group p.l.c. (GB) 1991-01-02 EP disclosed
EP-0404296-A1 Phosphono derivatives of purine with antiviral activity Beecham Group p.l.c. (GB) 1990-12-27 EP disclosed
EP-0399743-A1 Phosphonomethylthio-alkoseypureine derivatives, intermediate products for their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1990-11-28 EP disclosed
US-4965270-A Viricides BEECHAM GROUP P.L.C. (GB) 1990-10-23 US disclosed
US-4910307-A Process for preparing purines BEECHAM GROUP P.L.C. (GB) 1990-03-20 US disclosed
EP-0353955-A2 Novel compounds BEECHAM GROUP PLC (GB) 1990-02-07 EP disclosed
EP-0319228-A2 Novel compounds BEECHAM GROUP PLC (GB) 1989-06-07 EP disclosed
EP-0313289-A2 Process for the preparation of purine compounds and intermediates therefor BEECHAM GROUP PLC (GB) 1989-04-26 EP disclosed
EP-0242482-A2 Antiviral purine derivatives and process for their preparation BEECHAM GROUP PLC (GB) 1987-10-28 EP disclosed